Hepatic Surgery for Colorectal Cancer Metastasis — Possibilities and Prerequisites ( Recent Advances in Liver Diseases and Surgery )

Publication series ： Recent Advances in Liver Diseases and Surgery

Author： Ilze Strumfa Ervins Vasko Andrejs Vanags Zane Simtniece5

Publisher： IntechOpen‎

Publication year： 2015

E-ISBN: INT5973760971

P-ISBN(Paperback): 9789535121930

P-ISBN(Hardback): 9789535121930

Subject： R57 digestive system disease and coeliac disease

Keyword：消化系及腹部疾病

Language： ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Hepatic Surgery for Colorectal Cancer Metastasis — Possibilities and Prerequisites

Description

Colorectal cancer is among the most frequent malignant tumours. Liver metastases develop in 70–75% of patients affected by colorectal carcinoma. Nowadays, surgical treatment can significantly improve the 5-year survival ranging 40–58% of the patients undergoing liver surgery. The operation extent ranges from nonanatomic minor resection to major hepatectomy. Recently, liver transplantation has been performed for metastatic colorectal cancer. Laparoscopic approach and robotic surgery can be used by experienced specialists. The prerequisites for successful surgical treatment include exact radiologic diagnostics to determine the number and size of metastases and their association with anatomic structures; individual anatomic peculiarities and remnant liver volume, ranging 20–40% in respect to functional liver status. Magnetic resonance imaging is the most sensitive method that has marked advantages in the diagnostics of lesions smaller than 1 cm and metastases on the background of liver steatosis. Computed tomography is an acceptable alternative that benefits from high spatial resolution and optimal reconstructions to evaluate the anatomy. Additional information can be obtained from tumour markers, including traditional, e.g., carcinoembryonic antigen (CEA) and novel, e.g., microRNAs. To ensure that each colorectal cancer patient receives the best care, the medical society should be well informed about the possibilities in the treatment of liver metastases of colorectal cancer r